Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles
- 22 December 2016
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 24 (2) , 113-119
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 43 references indexed in Scilit:
- A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90Autophagy, 2014
- Tolerogenic dendritic cells and their role in transplantationSeminars in Immunology, 2011
- Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cellsNature Immunology, 2011
- Induction of Allergen-Specific Tolerance via Mucosal Routes2011
- Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequenceVaccine, 2009
- Function and Genetics of Dystrophin and Dystrophin-Related Proteins in MusclePhysiological Reviews, 2002
- Cytotoxic Immune Response Blunts Long-Term Transgene Expression after Efficient Retroviral-Mediated Hepatic Gene Transfer in RatMolecular Therapy, 2002
- Differential Control of Neonatal Tolerance by Antigen Dose versus Extended Exposure and AdjuvantCellular Immunology, 2000
- Immune responses, not promoter inactivation, are responsible for decreased long‐term expression following plasmid gene transfer into skeletal muscleFEBS Letters, 1997
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993